Allergy Diagnostics and Therapeutics Market 2025 to 2034
Allergy Diagnostics and Therapeutics Market 2025 to 2034
Allergy Diagnostics And Therapeutics Market (By Product: Instruments, Consumables, Services; By Drug Class: Nasal Anti-cholinergic, Antihistamines, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Epinephrine, Immunotherapy, Decongestants, Immuno-modulators; By Test: In vivo Test, In vitro Test; By Allergen Type: Food, Inhaled, Drug, Other Allergens; By End-user: Hospitals, Diagnostics Labs, Research & Development Centers, Others) – Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 38.76 Bn
Forecast Year, 2034
USD 70.77 Bn
CAGR, 2025 - 2034
6.93%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global allergy diagnostics and therapeutics market reached USD 38.76 billion in 2025 and is set to grow steadily, approaching USD 70.77 billion by 2034, driven by rising allergy prevalence, improved diagnostic tools, and advances in targeted therapies, at a CAGR of 6.93%.
Allergy Diagnostics and Therapeutics Market Size Analysis
Allergy Diagnostics and Therapeutics Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Instruments | 10.85 | 11.63 | 12.46 | 13.35 | 14.30 | 15.32 | 16.42 | 17.59 | 18.85 | 20.19 |
| Consumables | 18.22 | 19.52 | 20.91 | 22.41 | 24.01 | 25.72 | 27.56 | 29.53 | 31.64 | 33.89 |
| Services | 9.69 | 10.38 | 11.12 | 11.92 | 12.77 | 13.68 | 14.66 | 15.71 | 16.83 | 18.03 |
Allergy Diagnostics and Therapeutics Market Size By Drug Class 2025 to 2034 (USD Billion)
| Drug Class | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Nasal Anti-cholinergic | 2.71 | 2.86 | 3.01 | 3.17 | 3.34 | 3.52 | 3.71 | 3.91 | 4.12 | 4.35 |
| Antihistamines | 8.53 | 9.04 | 9.57 | 10.13 | 10.72 | 11.35 | 12.01 | 12.71 | 13.45 | 14.24 |
| Corticosteroids | 6.98 | 7.41 | 7.86 | 8.34 | 8.84 | 9.38 | 9.95 | 10.55 | 11.20 | 11.89 |
| Mast Cell Stabilizers | 3.10 | 3.27 | 3.45 | 3.64 | 3.84 | 4.06 | 4.29 | 4.53 | 4.79 | 5.07 |
| Leukotriene Inhibitors | 3.88 | 4.11 | 4.36 | 4.62 | 4.90 | 5.20 | 5.52 | 5.86 | 6.22 | 6.61 |
| Epinephrine | 2.33 | 2.45 | 2.58 | 2.72 | 2.87 | 3.03 | 3.20 | 3.38 | 3.57 | 3.77 |
| Immunotherapy | 5.81 | 6.25 | 6.73 | 7.25 | 7.81 | 8.42 | 9.08 | 9.80 | 10.57 | 11.42 |
| Decongestants | 3.49 | 3.69 | 3.91 | 4.14 | 4.39 | 4.66 | 4.95 | 5.26 | 5.60 | 5.96 |
| Immuno-modulators | 1.94 | 2.07 | 2.20 | 2.35 | 2.50 | 2.66 | 2.83 | 3.01 | 3.21 | 3.46 |
Allergy Diagnostics and Therapeutics Market Size By Test 2025 to 2034 (USD Billion)
| Test | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| In vitro Test | 24.03 | 25.75 | 27.59 | 29.56 | 31.67 | 33.93 | 36.35 | 38.95 | 41.73 | 44.71 |
| In vivo Test | 14.73 | 15.78 | 16.91 | 18.12 | 19.41 | 20.80 | 22.28 | 23.87 | 25.58 | 27.40 |
Allergy Diagnostics and Therapeutics Market Size By Allergen Type 2025 to 2034 (USD Billion)
| Allergen Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Food | 12.40 | 13.40 | 14.52 | 15.74 | 17.06 | 18.51 | 20.10 | 21.81 | 23.62 | 24.08 |
| Inhaled | 15.89 | 16.85 | 17.87 | 18.96 | 20.12 | 21.35 | 22.64 | 23.92 | 25.19 | 26.91 |
| Drug | 6.59 | 7.07 | 7.60 | 8.18 | 8.81 | 9.51 | 10.24 | 11.01 | 11.92 | 12.75 |
| Other Allergens | 3.88 | 4.12 | 4.32 | 4.50 | 4.67 | 4.80 | 4.94 | 5.19 | 5.49 | 7.07 |
Allergy Diagnostics and Therapeutics Market Size By End-user 2025 to 2034 (USD Billion)
| End-user | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 15.12 | 16.20 | 17.35 | 18.59 | 19.92 | 21.35 | 22.87 | 24.50 | 26.25 | 28.12 |
| Diagnostics Labs | 13.18 | 14.12 | 15.13 | 16.21 | 17.37 | 18.61 | 19.94 | 21.36 | 22.89 | 24.52 |
| Research & Development Centers | 6.59 | 7.06 | 7.56 | 8.10 | 8.68 | 9.30 | 9.97 | 10.68 | 11.44 | 12.26 |
| Others | 3.88 | 4.15 | 4.45 | 4.77 | 5.11 | 5.47 | 5.86 | 6.28 | 6.73 | 7.21 |
Allergy Diagnostics and Therapeutics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 14.34 | 15.37 | 16.46 | 17.64 | 18.90 | 20.25 | 21.70 | 23.25 | 24.90 | 26.68 |
| Europe | 10.08 | 10.80 | 11.57 | 12.40 | 13.28 | 14.23 | 15.25 | 16.34 | 17.50 | 18.75 |
| Asia Pacific | 9.69 | 10.38 | 11.12 | 11.92 | 12.77 | 13.68 | 14.66 | 15.71 | 16.83 | 18.03 |
| LAMEA | 4.65 | 4.98 | 5.34 | 5.72 | 6.13 | 6.57 | 7.04 | 7.54 | 8.08 | 8.65 |
Allergy Diagnostics and Therapeutics Market Size to Reach USD 70.77 Billion by 2034
The global allergy diagnostics and therapeutics market size surpassed USD 38.76 billion in 2025 and is predicted to reach around USD 70.77 billion by 2034 with a CAGR of 6.93%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
